SCHEMBL22201469

SCHEMBL22201469

c1cnc2cc(-c3ccncc3)nc(Nc3ccc4[nH]ccc4c3)c2c1

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FGFR2 P21802 1/20 0.62
FLT3 P36888 1/20 0.62
PRKD1 Q15139 1/20 0.53
PRKCH P24723 1/20 0.52
PRKCE Q02156 1/20 0.52
TGFBR1 P36897 1/20 0.50
EGFR P00533 7/20 0.46
FLT1 P17948 7/20 0.46
KDR P35968 1/20 0.46
KDM1A O60341 1/20 0.45
GRM4 Q14833 2/20 0.43
CYP1A2 P05177 1/20 0.43
SYK P43405 4/20 0.42
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22201257 0.85 FGFR2 (0.62) FGFR2FLT3PRKD1PRKCHPRKCE
SCHEMBL22201475 0.83 PRKCH (0.47) FGFR2FLT3PRKD1PRKCHPRKCE
SCHEMBL22201476 0.82 PRKCH (0.52) FGFR2FLT3PRKCHPRKCESYK
SCHEMBL22201381 0.82 PRKCH (0.51) FGFR2FLT3PRKCHPRKCETGFBR1
SCHEMBL22201449 0.82 PRKCH (0.51) FGFR2FLT3PRKCHPRKCEGRM4
SCHEMBL22201452 0.82 PRKCH (0.58) PRKCHPRKCETGFBR1SYKLMNA
SCHEMBL22201598 0.81 FGFR2 (0.65) FGFR2FLT3PRKD1PRKCHPRKCE
SCHEMBL22201640 0.80 PRKCH (0.52) FGFR2FLT3PRKCHPRKCEEGFR
SCHEMBL22803770 0.80 EGFR (0.58) FGFR2FLT3PRKD1TGFBR1EGFR
SCHEMBL30302532 0.80 EGFR (0.58) FGFR2FLT3PRKD1TGFBR1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020142748-A1 METHODS AND MATERIALS FOR INCREASING TRANSCRIPTION FACTOR EB POLYPEPTIDE LEVELS UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2020-07-09 WO disclosed